Remus Pharmaceuticals Limited — Others, 23-06-2025: Shareholders meeting

Remus Pharmaceuticals Limited has announced the successful approval of an ordinary resolution for issuing bonus shares through a postal ballot process. Over 52% of shareholders participated in voting, with 100% of the votes cast in favor of the bonus issue. This move will enhance shareholder value by increasing equity stakes without additional cost. The resolution was passed without any opposition, reflecting strong shareholder support and confidence in the company’s growth prospects. This issuance signals Remus Pharma's commitment to rewarding its investors and optimizing capital structure.